Tag: review
-
FDA rejects Chiasma’s drug to treat growth disorder
(Reuters) – The U.S. Food and Drug Administration has rejected Chiasma Inc’s experimental drug to treat adults with a type of growth disorder, the company said on Friday. Chiasma was evaluating the drug, Mycapssa, in patients with acromegaly, a growth disorder that can result in serious illness and premature death. The Food and Drug Administration…
-
FDA rejects Chiasma’s drug to treat growth disorder
(Reuters) – The U.S. Food and Drug Administration has rejected Chiasma Inc’s experimental drug to treat adults with a type of growth disorder, the company said on Friday. Chiasma was evaluating the drug, Mycapssa, in patients with acromegaly, a growth disorder that can result in serious illness and premature death. The Food and Drug Administration…
-
Prince recovering after emergency plane landing due to flu: report
Singer Prince was released from an Illinois hospital on Friday after he was hospitalized with the flu following an emergency plane landing, celebrity news outlet TMZ said. A representative for the singer told TMZ that Prince had performed in Atlanta on Thursday despite not feeling well from the flu, and felt worse after boarding a…
-
Prince recovering after emergency plane landing due to flu: report
Singer Prince was released from an Illinois hospital on Friday after he was hospitalized with the flu following an emergency plane landing, celebrity news outlet TMZ said. A representative for the singer told TMZ that Prince had performed in Atlanta on Thursday despite not feeling well from the flu, and felt worse after boarding a…
-
Many older black women miss out on targeted breast cancer drug
By Lisa Rapaport (Reuters Health) – Older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy with trastuzumab (Herceptin), a U.S. study suggests. When researchers examined data from Medicare, the U.S. health program for people over age 65, they found just…
-
Many older black women miss out on targeted breast cancer drug
By Lisa Rapaport (Reuters Health) – Older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy with trastuzumab (Herceptin), a U.S. study suggests. When researchers examined data from Medicare, the U.S. health program for people over age 65, they found just…